Elisabet Josefsson

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Texas A&M University System, Trinity College Dublin, Bioresearch Ireland. Active years: 2004-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elisabet Josefsson. Retrieved from https://idiyas.com/inventor/elisabet-josefsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 42.9

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 55(Granted Patents)

Location History:

Goteborg, SE (2010)
Göteborg, SE (2016)
Gothenburg, SE (2004 - 2022)

Company Filing History:

3 out of 1,328

Texas A&M University System

patents

3 out of 141

Trinity College Dublin

Glaxosmithkline Biologicals Sa

6. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2022

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11512118 - Treatment of microbial infections (2022-11-29),

2. 9637525 - Treatment of microbial infections (2017-05-02),

3. 9353160 - Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof (2016-05-31),

4. 7855272 - [object Object] (2010-12-21),

5. 7834151 - [object Object] (2010-11-16),

6. 7381793 - [object Object] (2008-06-03),

7. 6680195 - Extracellular matrix-binding proteins from staphylococcus aureus (2004-01-20),

Title: Elisabet Josefsson: Innovator in Microbial Infection Treatment

Introduction

Elisabet Josefsson is a prominent inventor based in Gothenburg, Sweden. She has made significant contributions to the field of microbial infection treatment, holding a total of seven patents. Her work focuses on developing improved microbial antigen vaccines and therapeutic compositions.

Latest Patents

Among her latest patents, one notable invention is directed towards improved microbial antigen vaccines, pharmaceutical compositions, immunogenic compositions, and antibodies. This invention specifically addresses the treatment of microbial infections, particularly those of bacterial origin, including Staphylococcal infections. The invention involves recombinant staphylococcal MSCRAMM or MSCRAMM-like proteins, or fragments thereof, designed to have reduced binding to their host ligands for therapeutic use.

Career Highlights

Elisabet has worked with esteemed organizations such as the Texas A&M University System and Bioresearch Ireland. Her career reflects a commitment to advancing medical science and improving treatment options for microbial infections.

Collaborations

Throughout her career, Elisabet has collaborated with notable professionals, including Timothy James Foster and Joseph M Patti. These collaborations have contributed to her innovative research and development efforts.

Conclusion

Elisabet Josefsson's work in the field of microbial infection treatment showcases her dedication to innovation and her impact on medical science. Her patents and collaborations highlight her role as a leading inventor in this critical area of research.

Profile summary based on public USPTO records.